Literature DB >> 8849351

The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration.

P J Christner1, J Peters, D Hawkins, L D Siracusa, S A Jiménez.   

Abstract

OBJECTIVE: To describe the histopathologic and biochemical characteristics of skin from the Tsk2/+ mouse, a mutation with phenotypic features resembling those of systemic sclerosis (SSc), and to report the initial genetic mapping of the Tsk2 locus.
METHODS: Histologic examination was performed and collagen content and type I collagen messenger RNA (mRNA) levels were determined in skin biopsy specimens from Tsk2/+ mice and normal mice. An intersubspecific backcross was conducted as a first step toward identifying the position of the Tsk2 locus on mouse chromosome 1.
RESULTS: Histologic examination of Tsk2/+ mouse skin revealed marked accumulation of collagen and infiltration with mononuclear cells in the dermis and adipose tissue. Biochemical studies of Tsk2/+ mouse skin showed increased collagen content and elevated steady-state levels of alpha 1 (I) procollagen mRNA. Tsk2 was mapped to a 15.3-centimorgan interval on mouse chromosome 1.
CONCLUSION: Tsk2 is a novel mutation which displays histopathologic and biochemical abnormalities similar to those present in the skin of patients with SSc, including increased collagen content and expression of type I collagen genes. This mutation has been mapped to a 15.3-cM region on mouse chromosome 1. Further study of this novel mutation will allow the identification of previously undescribed mechanisms involved in the regulation of normal and pathologic collagen gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8849351     DOI: 10.1002/art.1780381212

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

Review 1.  Animal models for scleroderma: an update.

Authors:  Yan Zhang; Anita C Gilliam
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 2.  Origin of fibrosing cells in systemic sclerosis.

Authors:  Sarah Ebmeier; Valerie Horsley
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

3.  Mouse Models of Skin Fibrosis.

Authors:  Aleix Rius Rigau; Markus Luber; Jörg H W Distler
Journal:  Methods Mol Biol       Date:  2021

4.  A high-resolution linkage map of the tight skin 2 (Tsk2) locus: a mouse model for scleroderma (SSc) and other cutaneous fibrotic diseases.

Authors:  P J Christner; L D Siracusa; D F Hawkins; R McGrath; J K Betz; S T Ball; S A Jimenez; J Peters
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

5.  A syndrome resembling human systemic sclerosis (scleroderma) in MRL/lpr mice lacking interferon-gamma (IFN-gamma) receptor (MRL/lprgammaR-/-).

Authors:  M Le Hir; M Martin; C Haas
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 6.  Animal models in scleroderma.

Authors:  Stephen H Clark
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 7.  Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.

Authors:  Kazuyuki Tsujino; Dean Sheppard
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 8.  Animal models of scleroderma: current state and recent development.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 9.  Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.

Authors:  Jennifer L Sargent; Michael L Whitfield
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

10.  Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.

Authors:  Jennifer L Sargent; Zhenghui Li; Antonios O Aliprantis; Matthew Greenblatt; Raphael Lemaire; Ming-Hua Wu; Jun Wei; Jaclyn Taroni; Adam Harris; Kristen B Long; Chelsea Burgwin; Carol M Artlett; Elizabeth P Blankenhorn; Robert Lafyatis; John Varga; Stephen H Clark; Michael L Whitfield
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.